Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer
Changhwan Sung, Jinhyeon An, Soo Hyun Lee, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 844-859
Closed Access | Times Cited: 23

Showing 23 citing articles:

Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 40
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 4
Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors
Ben Ponvilawan, Abdul Wali Khan, Janakiraman Subramanian, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1225-1225
Open Access | Times Cited: 11
Association of Baseline Tumor-Specific Neoantigens and CD8+ T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors
Csaba Kerepesi, Hassan Abushukair, Biagio Ricciuti, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 5
Recent Advances in Photosensitizer Materials for Light‐Mediated Tumor Therapy
Minle Chen, Qianru Zhu, Zhenzhen Zhang, et al.
Chemistry - An Asian Journal (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 4
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients
Daan Jan Willem Rauwerdink, Olivier J. van Not, Melissa de Meza, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2656-2656
Open Access | Times Cited: 4
Machine-Learning Parsimonious Prediction Model for Diagnostic Screening of Severe Hematological Adverse Events in Cancer Patients Treated with PD-1/PD-L1 Inhibitors: Retrospective Observational Study by Using the Common Data Model
Seok Jun Park, Seungwon Yang, Su-Hyun Lee, et al.
Diagnostics (2025) Vol. 15, Iss. 2, pp. 226-226
Open Access
Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Xinyu Zhang, Bei Zhang, Danfei Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Severe thyroiditis induced by sintilimab monotherapy in a patient with non-small cell lung cancer: a case report and literature review
Xiaolin Zhao, Xiaoyu Wang, Surui Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Artificial Intelligence Technologies for Managing High-Risk Patients With Immune-Related Adverse Events and Optimizing Timing
Fangjie Liu, Hui Li
Journal of Thoracic Oncology (2025) Vol. 20, Iss. 3, pp. e47-e48
Closed Access
The Benefits and Safety of Monoclonal Antibodies: Implications for Cancer Immunotherapy
Shuguang Zhang, Wen‐Ying Chen, Jihong Zhou, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 4335-4357
Open Access
Autoimmune-related adverse events induced by immune checkpoint inhibitors
Yini Sun, Ziyang Zhang, Jia Ke, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102556-102556
Closed Access
The pathogenesis of neurological immune-related adverse events following immune checkpoint inhibitor therapy
Magdalena Lerch, Sudarshini Ramanathan
Seminars in Immunology (2025) Vol. 78, pp. 101956-101956
Open Access
Sustained Secretion of CCL21 via an Implantable Cell Reservoir Hydrogel Enhances the Systemic Antitumor Effect of Radiotherapy
Chao Gao, Yan-Mei Zeng, Linyu Zhang, et al.
Nano Letters (2024) Vol. 24, Iss. 19, pp. 5894-5903
Closed Access | Times Cited: 2
Non-Contrasted CT Radiomics for SAH Prognosis Prediction
Dezhi Shan, Junjie Wang, Peng Qi, et al.
Bioengineering (2023) Vol. 10, Iss. 8, pp. 967-967
Open Access | Times Cited: 6
PD-L1-driven efficient enrichment and elimination of circulating cancer cells by magnetic MoSe2 nanosheet
Hongjie Huang, Binhua Zou, Shanlin Zhu, et al.
Nano Research (2023) Vol. 17, Iss. 5, pp. 4350-4358
Closed Access | Times Cited: 5
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors
Juan Chen, Jia-Si Liu, Junyan Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e009399-e009399
Open Access | Times Cited: 1
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy
Haochuan Ma, Dili Song, Haibo Zhang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Checking immunotoxicity risks of checkpoint blockade
Dietmar Rieder, Zlatko Trajanoski
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 779-780
Closed Access | Times Cited: 2
Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial
André Manuel da Silva Lopes, Sara Colomer‐Lahiguera, Célia Darnac, et al.
JMIR Research Protocols (2023) Vol. 12, pp. e48386-e48386
Open Access | Times Cited: 1
Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis
Zhenli Li, Tiezhu Yao, Guang Liu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 5
Open Access
A case report of hemophagocytic lymphohistiocytosis induced by toripalimab plus chemoradiotherapy in cervical cancer
Shuhua Wei, Hongbo Chen, Xiuwen Deng, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33816-e33816
Open Access
The potential role of lung microbiota and lauroylcarnitine in T-cell activation associated with checkpoint inhibitor pneumonitis
Wenyi Yu, Keqiang Wang, Yukun He, et al.
EBioMedicine (2024) Vol. 106, pp. 105267-105267
Open Access
Page 1

Scroll to top